Attorney Represents Women Across America in Yaz Injury Lawsuits Against Bayer NEW YORK, Sep 26, 2011 (BUSINESS WIRE) — The U.S. Food and Drug Administration issued a statement today that the FDA remains concerned, but has not yet reached a conclusion, about the potential increased risk of blood clots from Drospirenone-containing birth control pills such […]